Lymphatic metastasis; lymphangiochemotherapy of mammary cancer: ascitic form of rat mammary adenocarcinoma 13762
β Scribed by J. Carr; B. Dreher; I. Carr
- Publisher
- Springer
- Year
- 1983
- Tongue
- English
- Weight
- 607 KB
- Volume
- 1
- Category
- Article
- ISSN
- 0262-0898
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
ASGP-1, the major cell surface sialomucin of the 13762 ascites rat mammary adenocarcinoma, is at least 0.5% of the total ascites cell protein and has sulfate on 20% of its 0-linked oligosaccharide chains. We have used this system to investigate the 0-glycosylation pathway in these cells and to deter
## Abstract Metastasizing mammary adenocarcinoma 13762 in female Fischer rats has been used as a model for studying postoperative adjuvant chemotherapy, using methotrexate (Mtx) and 5βfluorouracil (5FU) either singly or in combinations. All animals that received postoperative adjuvant chemotherapy
## Abstract Rats cured of poorly immunogenic 13762A tumor by a combination of surgery and cyclophosphamide (CY) treatments produced peritoneal exudate cells (PEC) that prevented tumor growth when transferred to naive recipients, but they were ineffective against established tumor. A highly immunoge